CAMK2A and Anxiety: These findings indicate that chronic CNO-mediated hM3Dq DREADD activation of CamKIIα-positive forebrain excitatory neurons in adulthood does not evoke any change in anxiety-like behavior, during or in the short duration after the cessation of CNO treatment.